Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
about
Mendelian randomisation and causal inference in observational epidemiologyIntegrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease riskMendelian randomization studies: a review of the approaches used and the quality of reportingMultiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular diseaseClustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiologyMendelian Randomization for Strengthening Causal Inference in Observational StudiesHigh sensitivity micro-elastometry: applications in blood coagulopathy.Clinical correlation between N-terminal pro-B-type natriuretic peptide and angiographic coronary atherosclerosis.Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health.Plasma fibrinogen lever and risk of coronary heart disease among Chinese population: a systematic review and meta-analysisEffects of cigarette smoking on morphological features of platelets in healthy men.Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study.Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA StudyStrengthening causal inference in cardiovascular epidemiology through Mendelian randomization.Can haemostatic factors predict atherothrombosis?Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach.Randomised by (your) god: robust inference from an observational study design.The association between elevated levels of inflammation biomarkers and coronary artery disease and death.Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture.Association of an apolipoprotein E polymorphism with circulating cholesterols and hypertension: a meta-based Mendelian randomization analysis.Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies.Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population StudyElevated Fibrinogen Levels Are Associated with Risk of Pulmonary Embolism, but Not with Deep Venous Thrombosis
P2860
Q21144649-0712BB21-429F-4F53-8ACB-3B7A732A17E1Q24656975-9D4B90CE-9E08-469B-B6E8-202644E147B2Q26999349-5524D3A4-917A-4901-97B1-F3DB86C695B9Q28661433-DA03EA2F-A434-40A3-9487-9564766FD4C4Q28756441-53A12CC1-6F61-450B-AC04-BE6C7605DD0AQ29037397-AE482A90-27E6-419F-9CFC-045F34C81387Q30429501-1CDAF67A-8BB6-46DF-9921-345EA2FC3734Q33729553-FDEE6FD1-1D9B-4995-AE28-A800077E99BEQ33798485-6CE675AC-EA39-46C3-8C22-5B96CEF869AAQ34333952-31DA21EF-616D-441F-B977-71577C688FBDQ34568873-825F8F08-8270-4564-A982-061D4D1DB104Q34581653-88A7437E-ECDB-4B8B-B671-0CAFEA20FEB3Q35835815-46900091-298E-4668-BEC6-E85EA652CD21Q35856244-42953772-3F59-428C-BBEC-97E9510DC987Q36625170-F884BB9C-2715-4E67-9CD5-248F9CC30260Q36935873-403FED3B-6FFF-4E4E-BBF4-412C0AC0AFC2Q37143274-2A2B1288-C7D6-4B6F-9E76-7C461592EBC3Q37209749-2F957BA9-C92B-4F04-8079-8EE70899801DQ37843765-44FAE15A-6C55-4612-9DC9-E09B760412B4Q41216845-4EA9A3FD-A7AF-42ED-9938-680F5C254366Q43159238-EFF0272F-1BB7-4AD8-9B2E-47F8D1DD5464Q43212282-AB6F7AB0-527C-4495-BA84-56C17FF673D5Q48560063-3EA9D746-6970-4777-9972-467507268FDEQ53091867-7A934335-2A9B-4980-9C3F-BDF5371C2D6CQ53108096-419D69D1-6791-4C45-A4AA-FF3BE7D38D12Q57104944-94A53F16-3135-4F62-9C2F-A540606FC2ECQ58007565-692A057E-28D5-4605-95E5-047AF372785E
P2860
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@en
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@nl
type
label
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@en
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@nl
prefLabel
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@en
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@nl
P50
P1476
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
@en
P2093
Julie Milton
Shah Ebrahim
P304
P356
10.1161/01.ATV.0000183937.65887.9C
P407
P577
2005-10-01T00:00:00Z